Weijin J. Huang
No. 31 Huatuo Street
Daxing, 102629, China
Daxing, 102629, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: November 28, 2025
Immunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents aged 9 to 17 compared with young women.
Journal: Science bulletin
Published: September 23, 2025
iPSC-induced multilineage liver organoids, small intestinal organoids and brain organoids sustain pangenotype hepatitis E virus propagation.
Journal: Gut
Published: June 12, 2025
Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18-26 years: three-year follow-up data from a randomised clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: April 11, 2025
A dual-view deep learning-driven discovery of cinnamoyl anthranilic acid derivatives against orthopoxvirus through targeting host ITGB3.
Journal: European journal of medicinal chemistry
Published: January 16, 2025
Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost.
Journal: Signal transduction and targeted therapy
Published: December 30, 2024
Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1.
Journal: Nature communications
Published: November 26, 2024
Last Updated: 09/26/2026